| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |